Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 7/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | LIPE | Q05469 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2138799 | 0.85 | GCGR (0.47) | GCGRDHFRKDM4EALDH1A1KCNH2 | |
| SCHEMBL2784607 | 0.80 | DCTPP1 (0.43) | GCGRDHFRKDM4EALDH1A1TDP1 | |
| SCHEMBL728847 | 0.79 | KCNH2 (0.37) | GCGRDHFRKCNH2CNR1TDP1 | |
| SCHEMBL13510693 | 0.78 | ENPP1 (0.41) | KDM4EALDH1A1LMNA | |
| SCHEMBL25972605 | 0.77 | ALDH1A1 (0.41) | LTB4R2KDM4EALDH1A1MCL1TDP1 | |
| SCHEMBL25974619 | 0.76 | ALDH1A1 (0.41) | LTB4R2KDM4EALDH1A1LMNAPOLB | |
| SCHEMBL24945347 | 0.75 | ALDH1A1 (0.40) | LTB4R2KDM4EALDH1A1LMNAPOLB | |
| SCHEMBL13510696 | 0.75 | ALDH1A1 (0.38) | KDM4EALDH1A1LMNAPOLBMCL1 | |
| SCHEMBL15681411 | 0.75 | HSD11B1 (0.54) | ALDH1A1KCNH2HSD11B1 | |
| SCHEMBL24945348 | 0.73 | ALDH1A1 (0.41) | LTB4R2KDM4EALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8137822-B2 | Synthesis of phenyl-substituted polyfluoroanthenes and the use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20110180758-A1 | Light-emitting Material and Device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2011-07-28 | — | — | US | disclosed |
| US-20080213623-A1 | 7,10-bis(acryloyl, styryl, or glycidyl-substituted phenyl)fluoranthene polymerized in the presence of a nickel or palladium catalyst; photopolymerized after applied to film substrate for organic light-emitting diodes; improved stability, high efficiency and quantum yield, emission maximum in blue region | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110180758-A1 | Light-emitting Material and Device | OCIAD1, OCIAD2, DRD1 | GCGR 3679/4885DHFR 811/4885LTB4R2 591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.